<?xml version="1.0" encoding="UTF-8"?>

<rdf:RDF
   xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#"
   xmlns:rdfs="http://www.w3.org/2000/01/rdf-schema#"
   xmlns="http://purl.org/rss/1.0/"
   xmlns:dc="http://purl.org/dc/elements/1.1/"
   xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/"
   xmlns:dcterms="http://purl.org/dc/terms/"

>
<channel rdf:about="http://www.citeulike.org/about">
<pubDate>Thu, 24 Jul 2008 23:25:29 BST</pubDate>


	<title>CiteULike: AlfonsoVicenteSuarezs tolerance-models</title>
	<description>CiteULike: AlfonsoVicenteSuarezs tolerance-models</description>


	<link>http://www.citeulike.org/user/AlfonsoVicenteSuarez/tag/tolerance-models</link>
	<dc:publisher>CiteULike.org</dc:publisher>
	<dc:language>en-gb</dc:language>
	<dc:rights>Copyright &#169; 2004-2008 citeulike.org</dc:rights>
	<items>
    <rdf:Seq>
        <rdf:li rdf:resource="http://www.citeulike.org/user/AlfonsoVicenteSuarez/article/2911219"/>
        <rdf:li rdf:resource="http://www.citeulike.org/user/AlfonsoVicenteSuarez/article/1776829"/>
        <rdf:li rdf:resource="http://www.citeulike.org/user/AlfonsoVicenteSuarez/article/1776680"/>
        <rdf:li rdf:resource="http://www.citeulike.org/user/AlfonsoVicenteSuarez/article/1776643"/>
        <rdf:li rdf:resource="http://www.citeulike.org/user/AlfonsoVicenteSuarez/article/1776592"/>

	</rdf:Seq>
	</items>
	</channel>


<item rdf:about="http://www.citeulike.org/user/AlfonsoVicenteSuarez/article/2911219">
    <title>Tumor Growth Enhances Cross-Presentation Leading to Limited T Cell Activation without Tolerance</title>
    <link>http://www.citeulike.org/user/AlfonsoVicenteSuarez/article/2911219</link>
    <description>&lt;i&gt;J. Exp. Med., Vol. 195, No. 4. (11 February 2002), pp. 423-435.&lt;/i&gt;&lt;br /&gt;&lt;br /&gt;Using a tumor model of spontaneously arising insulinomas expressing a defined tumor-associated antigen, we investigated whether tumor growth promotes cross-presentation and tolerance of tumor-specific T cells. We found that an advanced tumor burden enhanced cross-presentation of tumor-associated antigens to high avidity tumor-specific T cells, inducing T cell proliferation and limited effector function in vivo. However, contrary to other models, tumor-specific T cells were not tolerized despite a high tumor burden. In fact, in tumor-bearing mice, persistence and responsiveness of adoptively transferred tumor-specific T cells were enhanced. Accordingly, a potent T cell-mediated antitumor response could be elicited by intravenous administration of tumor-derived peptide and agonistic anti-CD40 antibody or viral immunization and reimmunization. Thus, in this model, tumor growth promotes activation of high avidity tumor-specific T cells instead of tolerance. Therefore, the host remains responsive to T cell immunotherapy. 10.1084/jem.20010032</description>
    <dc:title>Tumor Growth Enhances Cross-Presentation Leading to Limited T Cell Activation without Tolerance</dc:title>

    <dc:creator>Linh Nguyen</dc:creator>
    <dc:creator>Alisha Elford</dc:creator>
    <dc:creator>Kiichi Murakami</dc:creator>
    <dc:creator>Kristine Garza</dc:creator>
    <dc:creator>Stephen Schoenberger</dc:creator>
    <dc:creator>Bernhard Odermatt</dc:creator>
    <dc:creator>Daniel Speiser</dc:creator>
    <dc:creator>Pamela Ohashi</dc:creator>
    <dc:identifier>doi:10.1084/jem.20010032</dc:identifier>
    <dc:source>J. Exp. Med., Vol. 195, No. 4. (11 February 2002), pp. 423-435.</dc:source>
    <dc:date>2008-06-20T17:43:30-00:00</dc:date>
    <prism:publicationYear>2002</prism:publicationYear>
    <prism:publicationName>J. Exp. Med.</prism:publicationName>
    <prism:volume>195</prism:volume>
    <prism:number>4</prism:number>
    <prism:startingPage>423</prism:startingPage>
    <prism:endingPage>435</prism:endingPage>
    <prism:category>tolerance-models</prism:category>
    <prism:category>tumor-rejection</prism:category>
</item>



<item rdf:about="http://www.citeulike.org/user/AlfonsoVicenteSuarez/article/1776829">
    <title>Intravenous injection of soluble antigen induces thymic and peripheral T-cell apoptosis -- Liblau et al. 93 (7): 3031 -- Proceedings of the National Academy of Sciences</title>
    <link>http://www.citeulike.org/user/AlfonsoVicenteSuarez/article/1776829</link>
    <description>&lt;i&gt;&lt;/i&gt;</description>
    <dc:title>Intravenous injection of soluble antigen induces thymic and peripheral T-cell apoptosis -- Liblau et al. 93 (7): 3031 -- Proceedings of the National Academy of Sciences</dc:title>

    <dc:date>2007-10-16T22:22:12-00:00</dc:date>
    <prism:category>tolerance-models</prism:category>
</item>



<item rdf:about="http://www.citeulike.org/user/AlfonsoVicenteSuarez/article/1776680">
    <title>T Cell Deletion in High Antigen Dose Therapy of Autoimmune Encephalomyelitis</title>
    <link>http://www.citeulike.org/user/AlfonsoVicenteSuarez/article/1776680</link>
    <description>&lt;i&gt;&lt;/i&gt;&lt;br /&gt;&lt;br /&gt;Encounters with antigen can stimulate T cells to become activated and proliferate, become nonresponsive to antigen, or to die. T cell death was shown to be a physiological response to interleukin-2-stimulated cell cycling and T cell receptor reengagement at high antigen doses. This feedback regulatory mechanism attenuates the immune response by deleting a portion of newly dividing, antigen-reactive T cells. This mechanism deleted autoreactive T cells and abrogated the clinical and pathological signs of autoimmune encephalomyelitis in mice after repetitive administration of myelin basic protein.</description>
    <dc:title>T Cell Deletion in High Antigen Dose Therapy of Autoimmune Encephalomyelitis</dc:title>

    <dc:creator>Jeffrey Critchfield</dc:creator>
    <dc:creator>Michael Racke</dc:creator>
    <dc:creator>Juan Zúñiga-Pflücker</dc:creator>
    <dc:creator>Barbara Cannella</dc:creator>
    <dc:creator>Cedric Raine</dc:creator>
    <dc:creator>Joan Goverman</dc:creator>
    <dc:creator>Michael Lenardo</dc:creator>
    <dc:date>2007-10-16T21:27:37-00:00</dc:date>
    <prism:category>tolerance-models</prism:category>
</item>



<item rdf:about="http://www.citeulike.org/user/AlfonsoVicenteSuarez/article/1776643">
    <title>Aqueous antigens induce in vivo tolerance selectively in IL-2- and IFN- gamma-producing (Th1) cells -- Burstein et al. 148 (12): 3687 -- The Journal of Immunology</title>
    <link>http://www.citeulike.org/user/AlfonsoVicenteSuarez/article/1776643</link>
    <description>&lt;i&gt;&lt;/i&gt;</description>
    <dc:title>Aqueous antigens induce in vivo tolerance selectively in IL-2- and IFN- gamma-producing (Th1) cells -- Burstein et al. 148 (12): 3687 -- The Journal of Immunology</dc:title>

    <dc:date>2007-10-16T21:14:35-00:00</dc:date>
    <prism:category>tolerance-models</prism:category>
</item>



<item rdf:about="http://www.citeulike.org/user/AlfonsoVicenteSuarez/article/1776592">
    <title>Antigen-specific tolerance strategies for the prevention and treatment of autoimmune disease : Article : Nature Reviews Immunology</title>
    <link>http://www.citeulike.org/user/AlfonsoVicenteSuarez/article/1776592</link>
    <description>&lt;i&gt;&lt;/i&gt;</description>
    <dc:title>Antigen-specific tolerance strategies for the prevention and treatment of autoimmune disease : Article : Nature Reviews Immunology</dc:title>

    <dc:date>2007-10-16T20:58:41-00:00</dc:date>
    <prism:category>tolerance-models</prism:category>
</item>



</rdf:RDF>

